ClinicalTrials.gov
ClinicalTrials.gov Menu

All-Trans Retinoic Acid in Combination With Standard Induction and Consolidation Therapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00151255
Recruitment Status : Completed
First Posted : September 8, 2005
Last Update Posted : April 19, 2017
Sponsor:
Information provided by (Responsible Party):
Prof. Dr. Richard Schlenk, University of Ulm